Currently out of the existing stock ratings of Christopher Pasquale, 7 are a HOLD (28%), 18 are a BUY (72%).

Christopher Pasquale

Work Performance Price Targets & Ratings Chart

Analyst Christopher Pasquale, currently employed carries an average stock price target met ratio of 59.85% that have a potential upside of 19.56% achieved within 137 days.

Christopher Pasquale’s has documented 45 price targets and ratings displayed on 11 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on PRCT, Procept Biorobotics Corp at 09-Mar-2022.

Wall Street Analyst Christopher Pasquale

Analyst best performing recommendations are on PRCT (PROCEPT BIOROBOTICS CORP).
The best stock recommendation documented was for PRCT (PROCEPT BIOROBOTICS CORP) at 10/11/2021. The price target of $45 was fulfilled within 2 days with a profit of $3.45 (8.3%) receiving and performance score of 41.52.

Average potential price target upside

of $19.04 (18.63%) on DXCM (DEXCOM).
of $14.68 (30.63%) on ABT (ABBOTT LABORATORIES).
of $9.82 (38.15%) on PRCT (PROCEPT BIOROBOTICS CORP).

DXCM DexCom ZBH Zimmer Biomet Holdings COO The Cooper Companies . Common Stock ABMD ABIOMED ABT Abbott Laboratories CSII Cardiovascular Systems INSP Inspire Medical Systems MDT Medtronic PLC PODD Insulet PRCT Procept Biorobotics Corp VRAY ViewRay

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Steven Lichtman (OPPENHEIMER)